Studies on quadriceps defects showed BPC-157 improved both structural healing and functional outcomes
In March, the FDA approved the first drug for metabolic dysfunction-associated steatohepatitis, Rezdiffra, which the company has priced at $47,400 per year before discounts or negotiation
There is currently no approved generic Ozempic (semaglutide)
Peptide therapy helps rewind time for a more vibrant appearance
Mild nausea, reduced appetite, or slight changes in digestion are common in week one and usually resolve within days as your body acclimates
Thyroid concerns In animal studies, Semaglutide has shown an increased risk of thyroid tumors, including medullary thyroid carcinoma (MTC)